What Is Better for Rotator Cuff Tendinopathy: Dextrose Prolotherapy, Platelet Rich Plasma or Corticosteroids Injections? A randomized control study

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

PACTR

Registry ID

PACTR202005610509496

Enrollment

Registered

2020-05-25

Start date

2018-07-22

Completion date

Unknown

Last updated

2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Musculoskeletal Diseases

Interventions

Prolotherapy injection

Platelet rich plasma injection

corticosteroids injections

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Rotator cuff tendinopathy (RCT) patients with symptoms for 3 months or more and with failed conservative treatment of at least 4 weeks

Exclusion criteria

Exclusion criteria: previous injection in the shoulder within 3 months, history of shoulder trauma, instability, rotator cuff full thickness tear, shoulder surgery, patients who were suffering from rheumatic diseases, hepatitis, hematological diseases, platelet value < 150,000 mm3, tumors or metastatic disease

Design outcomes

Primary

Measure	Time frame
The result of this study may offer clarity on which treatment approach might be better for rotator cuff tendinopathy and might aid as a guide for future management	—

Secondary

Measure	Time frame
Prolotherapy injection was superior to platelet rich plasma and steroid in treatment of rotator cuff tendinopathy .	—

Countries

Egypt

Contacts

Public ContactHala Mohammed Abd Elsabour

Lecturer of Physical Medicine Rheumatology and Rehabilitation

Halams@medu.asu.edu.eg01006720301

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Feb 17, 2026